Effect of Non-surgical Periodontal Treatment on Cardiovascular Risk Markers

NCT ID: NCT04305171

Last Updated: 2020-03-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-04-06

Study Completion Date

2020-02-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The research question was to investigate whether non-surgical periodontal therapy could reduce cardiovascular risk markers in Coronary heart disease (CHD) patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CHD patients or non-CHD with or without periodontitis were included. They were provided with non-surgical periodontal therapy (NSPT). Periodontal parameters and cardiovascular risk markers were measured at baseline and 3 months and 6 months after NSPT.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Heart Disease Periodontitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

coronary heart disease patients with periodontitis

Coronary heart disease patients confirmed through coronary angiography as having at least 50% diameter stenosis in at least one coronary artery and clinically stable with the absence of any potentially confounding inflammatory conditions for at least 6 months.

Periodontitis classified as havingbleeding on probing (BOP), pocket depth (PD) \> 4 mm, clinical attachment level (CAL) ≥ 5 mm and radiographic evidence of bone loss were presented at the same site of at least 4 teeth.

non-surgical periodontal treatment

Intervention Type PROCEDURE

scaling and root planing, home care instruction

coronary heart disease patients without periodontitisHD

Coronary heart disease patients confirmed through coronary angiography as having at least 50% diameter stenosis in at least one coronary artery and clinically stable with the absence of any potentially confounding inflammatory conditions for at least 6 months.

Non-periodontitis classified as having PD ≤ 3 mm.

non-surgical periodontal treatment

Intervention Type PROCEDURE

scaling and root planing, home care instruction

non-coronary heart disease patients with periodontitis

Periodontitis classified as havingbleeding on probing (BOP), pocket depth (PD) \> 4 mm, clinical attachment level (CAL) ≥ 5 mm and radiographic evidence of bone loss were presented at the same site of at least 4 teeth.

non-surgical periodontal treatment

Intervention Type PROCEDURE

scaling and root planing, home care instruction

non-coronary heart disease patients without periodontitis

Non-periodontitis classified as having PD ≤ 3 mm.

non-surgical periodontal treatment

Intervention Type PROCEDURE

scaling and root planing, home care instruction

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

non-surgical periodontal treatment

scaling and root planing, home care instruction

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* non-CHD or CHD (at least 50% diameter stenosis in at least one coronary artery and clinically stable with absence of any potentially confounding inflammatory conditions for at least 6 months)
* had at least 14 natural teeth excluding third molars

Exclusion Criteria

* received anticoagulant drugs
* had chronic conditions (e.g. diabetes mellitus, rheumatoid arthritis, malignancy, autoimmune disease) or acute conditions (e.g. trauma, surgery) or medications known to affect systemic inflammatory markers (e.g. antibiotics, immunosuppressive, contraceptives) within 3 months
* pregnancy or lactation
* presence or history of other infections
* periodontal treatment within 6 months
* tooth extractions within 2 months prior to the study.
Minimum Eligible Age

35 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Supanee Rassameemasmaung, PhD

Role: PRINCIPAL_INVESTIGATOR

Mahidol University Faculty of Dentistry

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University

Ratchathewi, Bangkok, Thailand

Site Status

Department of Medicine, Rajavithi Hospital

Ratchathewi, Bangkok, Thailand

Site Status

Mahidol University Faculty of Dentistry

Ratchathewi, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

References

Explore related publications, articles, or registry entries linked to this study.

Ye Z, Cao Y, Miao C, Liu W, Dong L, Lv Z, Iheozor-Ejiofor Z, Li C. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis. Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD009197. doi: 10.1002/14651858.CD009197.pub5.

Reference Type DERIVED
PMID: 36194420 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MU-DT/PY-IRB 2018/022.0504

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.